Osimertinib
Product Description
Shandong Boyuan Pharmaceutical Co., Ltd.
-
Country/Region:China
-
On CPHI since:2025
-
Certificates:2
-
Employees:500 - 999
Company types
Primary activities
Categories
Specifications
Shandong Boyuan Pharmaceutical Co., Ltd.
-
Country/Region:China
-
On CPHI since:2025
-
Certificates:2
-
Employees:500 - 999
Company types
Primary activities
More Products from Shandong Boyuan Pharmaceutical Co., Ltd. (99)
-
Product tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
Palbociclib Intermediate -
Product Trans-1,2-diaminocyclohexane-N,N,N'N',tetraacetic acid
Metal Chelating Agent -
Product Racecadotril
Antidiarrheal API
CEP -
Product Pemetrexed Disodium (7/2.5 H2O)
Antitumor API
CEP/NMPA-A -
Product Terbinafine Hydrochloride /Base
Antifungal API
CEP/NMPA-A/MFDS -
Product Ifosfamide
Antitumor API
DMF -
Product Oxaliplatin
Antitumor API
CEP/NMPA-A/PMDA/MFDS -
Product Carboplatin
Antitumor API
NMPA-A -
Product Capecitabine
Antitumor API
CEP/NMPA-A -
Product Palbociclib
Antitumor API
NMPA-I/PMDA-under review/MFDS -
Product Cenobamate
Antiepileptic API
DMF
![tert-butyl 4-(6-(8-cyclopentyl-5-Methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyriMidin-2-ylaMino)pyridin-3-yl)piperazine-1-carboxylate](https://www.cphi-online.com/img/v2021/product_image.png)
